Role of cGMP in the mechanism of anxiolytic activity of U-78875
- 30 June 1991
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 39 (2) , 379-382
- https://doi.org/10.1016/0091-3057(91)90195-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The gaba/benzodiazepine receptor — chloride ionophore complex: Nature and modulationProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1987
- Interaction of benzodiazepine receptor agonists and inverse agonists with the GABA benzodiazepine receptor complexPharmacology Biochemistry and Behavior, 1985
- Endogenous ligands for benzodiazepine recognition sitesBiochemical Pharmacology, 1985
- The benzodiazepine antagonist Ro 15–1788 reverses the effect of methyl-β-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in miceEuropean Journal of Pharmacology, 1985
- Benzodiazepines stimulate muscimol receptor binding in an Ro 15-1788 reversible mannerEuropean Journal of Pharmacology, 1983
- Stress-induced alterations of cyclic nucleotide levels in brain: Effects of centrally acting drugsPsychopharmacology, 1977
- Effect of desmethyldiazepam and chlordesmethyldiazepam on 3?,5?-cyclic guanosine monophosphate levels in rat cerebellumPsychopharmacology, 1976
- Effects of stress on mouse brain cyclic nucleotide levels in vivoBrain Research, 1975
- New concepts on the mechanism of action of benzodiazepinesLife Sciences, 1975
- Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action of diazepamNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1975